Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair

Gene Therapy for Bone Regeneration

(2013) Michael J. Pensak et al.   CURRENT PHARMACEUTICAL DESIGN

2A to the Fore – Research, Technology and Applications

(2011) Garry A. Luke et al.   Biotechnology & Genetic Engineering Reviews

Combination gene therapy using VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric carcinoma growth

(2011) Ting Liu et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

In vitro and in vivo comparison of viral and cellular internal ribosome entry sites for bicistronic vector expression

(2011) M Licursi et al.   GENE THERAPY

Stem Cell Based Cancer Gene Therapy

(2011) Marina Cihova et al.   MOLECULAR PHARMACEUTICS

“Same Day” Ex-vivo Regional Gene Therapy: A Novel Strategy to Enhance Bone Repair

(2011) Mandeep S Virk et al.   MOLECULAR THERAPY

All-trans retinoic acid enhances bystander effect of suicide-gene therapy against medulloblastomas

(2011) Shaoyi Li et al.   NEUROSCIENCE LETTERS

High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice

(2011) Jin Hee Kim et al.   PLoS One

Postoperative Cervical Myelopathy and Cord Compression Associated with the Use of Recombinant Bone Morphogenetic Protein-2 in Posterior Cervical Decompression, Instrumentation, and Arthrodesis

(2011) David W. Anderson et al.   SPINE

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned

(2011) Eugene J. Carragee et al.   Spine Journal

HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells

(2009) Miroslava Matuskova et al.   CANCER LETTERS

Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model

(2008) Mandeep Singh Virk et al.   BONE

Prodrug cancer gene therapy

(2008) Cestmir Altaner   CANCER LETTERS